Advertisement

Regulation of Mesenchymal Stem Cell Differentiation

  • David Cook
  • Paul GeneverEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 786)

Abstract

A population of multipotent stromal cells exists within bone marrow and other adult tissues, which is able to differentiate into different skeletal tissues such as bone, cartilage and fat. These cells are frequently referred to as mesenchymal stem cells (MSCs) and offer significant therapeutic potential, particularly in orthopaedic applications, but may also have broader roles in regenerative medicine, cancer treatment, as anti-inflammatories, immunosuppressives and vehicles for gene/protein therapy. Much attention has focused on understanding MSC biology and the regulation of differentiation to help realise these clinical aspirations. Here we review some of the key molecular determinants of MSC function, with an emphasis on transcription factor control and the cell-cell signalling pathways that regulate MSC differentiation. The source information comes from a range of different models, including isolated human MSC cultures, animal-derived MSC-like cell lines, animal models and skeletal developmental processes to provide a wide-angled overview of the important players in MSC biology and tri-lineage specification.

Keywords

Mesenchymal stem cells Osteogenesis Chondrogenesis Adipogenesis Transcriptional control 

References

  1. 1.
    Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16(3):381–390PubMedGoogle Scholar
  2. 2.
    Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393–403PubMedGoogle Scholar
  3. 3.
    Pittenger MF et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147PubMedGoogle Scholar
  4. 4.
    Horwitz EM et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99(13):8932–8937PubMedGoogle Scholar
  5. 5.
    Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315–317PubMedGoogle Scholar
  6. 6.
    Jackson A et al (2005) Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36(4):585–598PubMedGoogle Scholar
  7. 7.
    Kulkarni NH et al (2006) Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21(6):910–920PubMedGoogle Scholar
  8. 8.
    da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204–2213PubMedGoogle Scholar
  9. 9.
    Banerjee C et al (2001) Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142(9):4026–4039PubMedGoogle Scholar
  10. 10.
    Jaiswal N et al (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64(2):295–312PubMedGoogle Scholar
  11. 11.
    Samulin J et al (2008) Differential gene expression of fatty acid binding proteins during porcine adipogenesis. Comp Biochem Physiol B Biochem Mol Biol 151(2):147–152PubMedGoogle Scholar
  12. 12.
    Pelttari K, Steck E, Richter W (2008) The use of mesenchymal stem cells for chondrogenesis. Injury 39(suppl 1):S58–S65PubMedGoogle Scholar
  13. 13.
    Marie PJ (2008) Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473(2):98–105PubMedGoogle Scholar
  14. 14.
    Ducy P et al (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747–754PubMedGoogle Scholar
  15. 15.
    Komori T et al (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755–764PubMedGoogle Scholar
  16. 16.
    Xiao ZS et al (1998) Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214(1–2):187–197PubMedGoogle Scholar
  17. 17.
    Zheng H et al (2004) Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 74(2):194–203PubMedGoogle Scholar
  18. 18.
    Takahashi T (2011) Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3T3-L1 preadipocytes into bone-forming osteoblasts in vitro. Calcif Tissue Int 88(4):336–347Google Scholar
  19. 19.
    Phillips JE et al (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119(Pt 3):581–591PubMedGoogle Scholar
  20. 20.
    Shui C et al (2003) Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18(2):213–221PubMedGoogle Scholar
  21. 21.
    Nakashima K et al (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108(1):17–29PubMedGoogle Scholar
  22. 22.
    Wu L et al (2007) Osteogenic differentiation of adipose derived stem cells promoted by overexpression of osterix. Mol Cell Biochem 301(1–2):83–92PubMedGoogle Scholar
  23. 23.
    Tu Q, Valverde P, Chen J (2006) Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 341(4):1257–1265PubMedGoogle Scholar
  24. 24.
    Kurata H et al (2007) Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 13(7):1513–1523PubMedGoogle Scholar
  25. 25.
    Chen X et al (1996) Dlx5 and Dlx6: an evolutionary conserved pair of murine homeobox genes expressed in the embryonic skeleton. Ann N Y Acad Sci 785:38–47PubMedGoogle Scholar
  26. 26.
    Tadic T et al (2002) Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation. J Bone Miner Res 17(6):1008–1014PubMedGoogle Scholar
  27. 27.
    Depew MJ et al (1999) Dlx5 regulates regional development of the branchial arches and sensory capsules. Development 126(17):3831–3846PubMedGoogle Scholar
  28. 28.
    Robledo RF et al (2002) The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16(9):1089–1101PubMedGoogle Scholar
  29. 29.
    Hassan MQ et al (2004) Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24(20):9248–9261PubMedGoogle Scholar
  30. 30.
    Dodig M et al (1999) Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 209(2):298–307PubMedGoogle Scholar
  31. 31.
    Mueller E et al (2002) Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J Biol Chem 277(44):41925–41930PubMedGoogle Scholar
  32. 32.
    Tontonoz P et al (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8(10):1224–1234PubMedGoogle Scholar
  33. 33.
    Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci U S A 92(21):9856–9860PubMedGoogle Scholar
  34. 34.
    Rosen ED et al (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16(1):22–26PubMedGoogle Scholar
  35. 35.
    Akune T et al (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113(6):846–855PubMedGoogle Scholar
  36. 36.
    Freytag SO, Paielli DL, Gilbert JD (1994) Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 8(14):1654–1663PubMedGoogle Scholar
  37. 37.
    Lin FT, Lane MD (1992) Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 6(4):533–544PubMedGoogle Scholar
  38. 38.
    Linhart HG et al (2001) C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci U S A 98(22):12532–12537PubMedGoogle Scholar
  39. 39.
    Yeh WC et al (1995) Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9(2):168–181PubMedGoogle Scholar
  40. 40.
    Rosen ED et al (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4(4):611–617PubMedGoogle Scholar
  41. 41.
    Wu Z et al (1999) Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3(2):151–158PubMedGoogle Scholar
  42. 42.
    Kim JB, Spiegelman BM (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10(9):1096–1107PubMedGoogle Scholar
  43. 43.
    Fajas L et al (1999) Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol 19(8):5495–5503PubMedGoogle Scholar
  44. 44.
    Tang QQ, Lane MD (2000) Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Proc Natl Acad Sci U S A 97(23):12446–12450PubMedGoogle Scholar
  45. 45.
    Moldes M et al (1999) Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem J 344(Pt 3):873–880PubMedGoogle Scholar
  46. 46.
    Tong Q et al (2000) Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290(5489):134–138PubMedGoogle Scholar
  47. 47.
    Tong Q et al (2005) Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 25(2):706–715PubMedGoogle Scholar
  48. 48.
    Zhao Q et al (1997) Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209(4):377–386PubMedGoogle Scholar
  49. 49.
    Akiyama H et al (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16(21):2813–2828PubMedGoogle Scholar
  50. 50.
    Ikeda T et al (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50(11):3561–3573PubMedGoogle Scholar
  51. 51.
    Frith J, Genever P (2008) Transcriptional control of mesenchymal stem cell differentiation. Transfus Med Hemother 35(3):216–227PubMedGoogle Scholar
  52. 52.
    Smits P et al (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1(2):277–290PubMedGoogle Scholar
  53. 53.
    Lefebvre V, Behringer RR, de Crombrugghe B (2001) L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthr Cartil 9(suppl A):S69–S75PubMedGoogle Scholar
  54. 54.
    Bridgewater LC, Lefebvre V, de Crombrugghe B (1998) Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273(24):14998–15006PubMedGoogle Scholar
  55. 55.
    Saito T et al (2007) S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep 8(5):504–509PubMedGoogle Scholar
  56. 56.
    Kim IS et al (1999) Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80(2):159–170PubMedGoogle Scholar
  57. 57.
    Enomoto-Iwamoto M et al (2001) Participation of Cbfa1 in regulation of chondrocyte maturation. Osteoarthr Cartil 9(suppl A):S76–S84PubMedGoogle Scholar
  58. 58.
    Boyden LM et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346(20):1513–1521PubMedGoogle Scholar
  59. 59.
    Yamaguchi A, Komori T, Suda T (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21(4):393–411PubMedGoogle Scholar
  60. 60.
    Shimoyama A et al (2007) Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18(7):2411–2418PubMedGoogle Scholar
  61. 61.
    Ling L, Nurcombe V, Cool SM (2009) Wnt signaling controls the fate of mesenchymal stem cells. Gene 433(1–2):1–7PubMedGoogle Scholar
  62. 62.
    Gong Y et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4):513–523PubMedGoogle Scholar
  63. 63.
    Babij P et al (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18(6):960–974PubMedGoogle Scholar
  64. 64.
    Bodine PV et al (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18(5):1222–1237PubMedGoogle Scholar
  65. 65.
    Bennett CN et al (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102(9):3324–3329PubMedGoogle Scholar
  66. 66.
    Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116(5):1202–1209PubMedGoogle Scholar
  67. 67.
    Clement-Lacroix P et al (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A 102(48):17406–17411PubMedGoogle Scholar
  68. 68.
    Gaur T et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280(39):33132–33140PubMedGoogle Scholar
  69. 69.
    Boland GM et al (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93(6):1210–1230PubMedGoogle Scholar
  70. 70.
    Baksh D, Boland GM, Tuan RS (2007) Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem 101(5):1109–1124PubMedGoogle Scholar
  71. 71.
    Eijken M et al (2008) Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem 104(2):568–579PubMedGoogle Scholar
  72. 72.
    Quarto N, Behr B, Longaker MT (2010) Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering. Tissue Eng Part A 16(10):3185–3197Google Scholar
  73. 73.
    Kahler RA et al (2006) Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J Cell Biochem 97(5):969–983PubMedGoogle Scholar
  74. 74.
    Prestwich TC, Macdougald OA (2007) Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19(6):612–617PubMedGoogle Scholar
  75. 75.
    Bennett CN et al (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277(34):30998–31004PubMedGoogle Scholar
  76. 76.
    Okamura M et al (2009) COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis. Proc Natl Acad Sci U S A 106(14):5819–5824PubMedGoogle Scholar
  77. 77.
    Liu G et al (2009) Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 185(1):67–75PubMedGoogle Scholar
  78. 78.
    Day TF et al (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8(5):739–750PubMedGoogle Scholar
  79. 79.
    Dong YF et al (2006) Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208(1):77–86PubMedGoogle Scholar
  80. 80.
    Im GI, Lee JM, Kim HJ (2011) Wnt inhibitors enhance chondrogenesis of human mesenchymal stem cells in a long-term pellet culture. Biotechnol Lett 33(5):1061–1068Google Scholar
  81. 81.
    Long F et al (2004) Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131(6):1309–1318PubMedGoogle Scholar
  82. 82.
    St-Jacques B, Hammerschmidt M, McMahon AP (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13(16):2072–2086PubMedGoogle Scholar
  83. 83.
    Hu H et al (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132(1):49–60PubMedGoogle Scholar
  84. 84.
    Bitgood MJ, McMahon AP (1995) Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 172(1):126–138PubMedGoogle Scholar
  85. 85.
    Deschaseaux F, Sensebe L, Heymann D (2009) Mechanisms of bone repair and regeneration. Trends Mol Med 15(9):417–429PubMedGoogle Scholar
  86. 86.
    Vortkamp A et al (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273(5275):613–622PubMedGoogle Scholar
  87. 87.
    Sampath TK et al (1992) Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267(28):20352–20362PubMedGoogle Scholar
  88. 88.
    Valcourt U, Moustakas A (2005) BMP signaling in osteogenesis, bone remodeling and repair. Eur J Trauma 31(5):464–479Google Scholar
  89. 89.
    Gitelman SE et al (1995) Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ 6(7):827–836PubMedGoogle Scholar
  90. 90.
    Lee KS et al (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20(23):8783–8792PubMedGoogle Scholar
  91. 91.
    Lee MH et al (2003) BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278(36):34387–34394PubMedGoogle Scholar
  92. 92.
    Zaidi SK et al (2002) Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci USA 99(12):8048–8053PubMedGoogle Scholar
  93. 93.
    Lee MH et al (2003) BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309(3):689–694PubMedGoogle Scholar
  94. 94.
    De Luca F et al (2001) Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology 142(1):430–436PubMedGoogle Scholar
  95. 95.
    Semba I et al (2000) Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by Sox9 and Msx2. Dev Dyn 217(4):401–414PubMedGoogle Scholar
  96. 96.
    Murtaugh LC et al (2001) The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis. Dev Cell 1(3):411–422PubMedGoogle Scholar
  97. 97.
    Lengner CJ et al (2005) Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation. J Biol Chem 280(16):15872–15879PubMedGoogle Scholar
  98. 98.
    Zeng L et al (2002) Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16(15):1990–2005PubMedGoogle Scholar
  99. 99.
    Alliston T et al (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20(9):2254–2272PubMedGoogle Scholar
  100. 100.
    Lutz M, Knaus P (2002) Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 14(12):977–988PubMedGoogle Scholar
  101. 101.
    Benfey PN (2003) Molecular biology: microRNA is here to stay. Nature 425(6955):244–245PubMedGoogle Scholar
  102. 102.
    Li Z et al (2008) A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 105(37):13906–13911PubMedGoogle Scholar
  103. 103.
    Hassan MQ et al (2010) A network connecting Runx2, SATB2, and the miR-23a ∼ 27a ∼ 24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 107(46):19879–19884Google Scholar
  104. 104.
    McMahon LA et al (2008) Regulatory effects of mechanical strain on the chondrogenic differentiation of MSCs in a collagen-GAG scaffold: experimental and computational analysis. Ann Biomed Eng 36(2):185–194PubMedGoogle Scholar
  105. 105.
    Sim WY et al (2007) A pneumatic micro cell chip for the differentiation of human mesenchymal stem cells under mechanical stimulation. Lab Chip 7(12):1775–1782PubMedGoogle Scholar
  106. 106.
    Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7(6):259–264PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Department of Biology (Area 9)University of YorkYorkUK

Personalised recommendations